FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096658049> ?p ?o ?g. }

• W2096658049 endingPage "1183" @default.
• W2096658049 startingPage "1175" @default.
• W2096658049 abstract "Background— CD133 (AC133) is a surface antigen that defines a broad population of stem cells, including myogenic and endothelial progenitors. CD133 + cells are rare in adult tissues, and the factors that support their differentiation into mature angiomyogenic cells are not known. These hurdles have hampered the use of CD133 + cells for therapeutic purposes. Because human fetal liver is a rich source of CD133 + cells, we sought to identify the growth factors that promote codifferentiation of these cells into angiogenic and myogenic cells. Methods and Results— Human fetal liver CD133 + and CD133 − cell subpopulations were cultured with 5′-azacytidine or vascular endothelial growth factor (VEGF 165 ) and/or brain-derived nerve growth factor (BDNF). CD133 + but not CD133 − cells from human fetal liver codifferentiated into spindle-shaped cells, as well as flat adherent multinucleated cells capable of spontaneous contractions in culture. The resulting spindle-shaped cells were confirmed to be endothelial cells by immunohistochemistry analysis for von Willebrand factor and by acetylated LDL uptake. Multinucleated cells were characterized as striated muscles by electron microscopy and immunohistochemistry analysis for myosin heavy chain. Presence of VEGF 165 and BDNF significantly enhanced angiomyogenesis in vitro. Inoculation of cells derived from CD133 + cells, but not CD133 − cells, into the ear pinna of NOD/SCID mice resulted in the formation of cardiomyocytes, as identified by immunostaining with cardiac troponin-T antibody. These cells generated electrical action potentials, detectable by ECG tracing. Conclusions— CD133 defines a population of human fetal liver cells capable of differentiating into both angiogenic and myogenic cells. Preconditioning of these CD133 + cells with VEGF 165 and BDNF enhances the angiomyogenesis. CD133 + fetal liver cells ultimately may be used for therapeutic angiomyogenesis." @default.
• W2096658049 created "2016-06-24" @default.
• W2096658049 creator A5023169167 @default.
• W2096658049 creator A5026587930 @default.
• W2096658049 creator A5030222654 @default.
• W2096658049 creator A5031506654 @default.
• W2096658049 creator A5041023019 @default.
• W2096658049 creator A5041736531 @default.
• W2096658049 creator A5041833617 @default.
• W2096658049 creator A5052599939 @default.
• W2096658049 creator A5062154339 @default.
• W2096658049 creator A5066503302 @default.
• W2096658049 creator A5074204079 @default.
• W2096658049 creator A5077328506 @default.
• W2096658049 creator A5077594914 @default.
• W2096658049 creator A5086974646 @default.
• W2096658049 creator A5090799132 @default.
• W2096658049 date "2005-03-08" @default.
• W2096658049 modified "2023-09-26" @default.
• W2096658049 title "Cytokine Preconditioning Promotes Codifferentiation of Human Fetal Liver CD133 ⁺ Stem Cells Into Angiomyogenic Tissue" @default.
• W2096658049 cites W116758555 @default.
• W2096658049 cites W133253872 @default.
• W2096658049 cites W1502896205 @default.
• W2096658049 cites W1540720871 @default.
• W2096658049 cites W1631250427 @default.
• W2096658049 cites W1954362343 @default.
• W2096658049 cites W2000292756 @default.
• W2096658049 cites W2001573748 @default.
• W2096658049 cites W2011053712 @default.
• W2096658049 cites W2028735060 @default.
• W2096658049 cites W2040663243 @default.
• W2096658049 cites W2040751142 @default.
• W2096658049 cites W2054784483 @default.
• W2096658049 cites W2065737043 @default.
• W2096658049 cites W2067941943 @default.
• W2096658049 cites W2068380542 @default.
• W2096658049 cites W2075344844 @default.
• W2096658049 cites W2084567069 @default.
• W2096658049 cites W2089846570 @default.
• W2096658049 cites W2090041902 @default.
• W2096658049 cites W2096856910 @default.
• W2096658049 cites W2098892229 @default.
• W2096658049 cites W2104898886 @default.
• W2096658049 cites W2116808589 @default.
• W2096658049 cites W2125155374 @default.
• W2096658049 cites W2131388270 @default.
• W2096658049 cites W2143410630 @default.
• W2096658049 cites W2157289201 @default.
• W2096658049 cites W2164506013 @default.
• W2096658049 cites W2165276410 @default.
• W2096658049 cites W2313374973 @default.
• W2096658049 cites W2340133576 @default.
• W2096658049 doi "https://doi.org/10.1161/01.cir.0000157155.44008.0f" @default.
• W2096658049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15753226" @default.
• W2096658049 hasPublicationYear "2005" @default.
• W2096658049 type Work @default.
• W2096658049 sameAs 2096658049 @default.
• W2096658049 citedByCount "53" @default.
• W2096658049 countsByYear W20966580492012 @default.
• W2096658049 countsByYear W20966580492013 @default.
• W2096658049 countsByYear W20966580492014 @default.
• W2096658049 countsByYear W20966580492015 @default.
• W2096658049 countsByYear W20966580492016 @default.
• W2096658049 countsByYear W20966580492018 @default.
• W2096658049 countsByYear W20966580492020 @default.
• W2096658049 crossrefType "journal-article" @default.
• W2096658049 hasAuthorship W2096658049A5023169167 @default.
• W2096658049 hasAuthorship W2096658049A5026587930 @default.
• W2096658049 hasAuthorship W2096658049A5030222654 @default.
• W2096658049 hasAuthorship W2096658049A5031506654 @default.
• W2096658049 hasAuthorship W2096658049A5041023019 @default.
• W2096658049 hasAuthorship W2096658049A5041736531 @default.
• W2096658049 hasAuthorship W2096658049A5041833617 @default.
• W2096658049 hasAuthorship W2096658049A5052599939 @default.
• W2096658049 hasAuthorship W2096658049A5062154339 @default.
• W2096658049 hasAuthorship W2096658049A5066503302 @default.
• W2096658049 hasAuthorship W2096658049A5074204079 @default.
• W2096658049 hasAuthorship W2096658049A5077328506 @default.
• W2096658049 hasAuthorship W2096658049A5077594914 @default.
• W2096658049 hasAuthorship W2096658049A5086974646 @default.
• W2096658049 hasAuthorship W2096658049A5090799132 @default.
• W2096658049 hasConcept C123012128 @default.
• W2096658049 hasConcept C142724271 @default.
• W2096658049 hasConcept C201750760 @default.
• W2096658049 hasConcept C202751555 @default.
• W2096658049 hasConcept C203014093 @default.
• W2096658049 hasConcept C28328180 @default.
• W2096658049 hasConcept C2908647359 @default.
• W2096658049 hasConcept C55493867 @default.
• W2096658049 hasConcept C71924100 @default.
• W2096658049 hasConcept C86803240 @default.
• W2096658049 hasConcept C95444343 @default.
• W2096658049 hasConcept C99454951 @default.
• W2096658049 hasConceptScore W2096658049C123012128 @default.
• W2096658049 hasConceptScore W2096658049C142724271 @default.
• W2096658049 hasConceptScore W2096658049C201750760 @default.
• W2096658049 hasConceptScore W2096658049C202751555 @default.
• W2096658049 hasConceptScore W2096658049C203014093 @default.

• next